These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36001830)

  • 1. Quantitative gait analysis in children with osteogenesis imperfecta: relationship between gait deviations and clinical features.
    De Wouters S; Detrembleur C; Durnez A; Mahaudens P; Henry B; Schrooyen J; Docquier PL
    Acta Orthop Belg; 2022 Jun; 88(2):255-262. PubMed ID: 36001830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gait Deviations in Children With Osteogenesis Imperfecta Type I.
    Garman CR; Graf A; Krzak J; Caudill A; Smith P; Harris G
    J Pediatr Orthop; 2019 Sep; 39(8):e641-e646. PubMed ID: 31393309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials.
    Hald JD; Evangelou E; Langdahl BL; Ralston SH
    J Bone Miner Res; 2015 May; 30(5):929-33. PubMed ID: 25407702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis Imperfecta-Who Needs Rodding Surgery?
    Fassier FR
    Curr Osteoporos Rep; 2021 Jun; 19(3):264-270. PubMed ID: 33646506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of withdrawal of bracing in matched pairs of children with osteogenesis imperfecta.
    Gerber LH; Binder H; Berry R; Siegel KL; Kim H; Weintrob J; Lee YJ; Mizell S; Marini J
    Arch Phys Med Rehabil; 1998 Jan; 79(1):46-51. PubMed ID: 9440417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta].
    Kokavec M; Novorolský K; Pribilincová Z
    Acta Chir Orthop Traumatol Cech; 2008 Jun; 75(3):185-9. PubMed ID: 18601816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta.
    Dimeglio LA; Ford L; McClintock C; Peacock M
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):43-53. PubMed ID: 15679068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Otaify GA; Aglan MS; Ibrahim MM; Elnashar M; El Banna RA; Temtamy SA
    Osteoporos Int; 2016 Jan; 27(1):81-92. PubMed ID: 26138583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of bone density measurements in children with osteogenesis imperfecta.
    Huang RP; Ambrose CG; Sullivan E; Haynes RJ
    J Bone Joint Surg Am; 2006 Jun; 88(6):1324-30. PubMed ID: 16757767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.
    Aström E; Jorulf H; Söderhäll S
    Arch Dis Child; 2007 Apr; 92(4):332-8. PubMed ID: 17114205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for Improving Bone Mineral Density and Reducing Fracture Risk in Osteogenesis Imperfecta: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K; Sivaramakrishnan G
    Curr Clin Pharmacol; 2018; 13(3):190-198. PubMed ID: 30160216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.
    Sakkers R; Kok D; Engelbert R; van Dongen A; Jansen M; Pruijs H; Verbout A; Schweitzer D; Uiterwaal C
    Lancet; 2004 May; 363(9419):1427-31. PubMed ID: 15121405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musculoskeletal System and Gait Characteristics in Patients with Osteogenesis imperfecta.
    Graff K; Kalinowska M; Szczerbik E; Kaczmarczyk K; Syczewska M
    Clin Rehabil; 2024 Aug; 38(8):1130-1140. PubMed ID: 38767090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenesis imperfecta: questions and answers.
    Shapiro JR; Sponsellor PD
    Curr Opin Pediatr; 2009 Dec; 21(6):709-16. PubMed ID: 19907330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the bone mineral density investigation through measuring of peripheral dual-energetic x-ray absorption in prevention of fractures in children with osteogenesis imperfecta].
    Saganelidze KhZ
    Georgian Med News; 2005 Mar; (120):61-4. PubMed ID: 15855703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta.
    Huber MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.